Matinas BioPharma Holdings, Inc.

MTNBAMEXUSD
0.59 USD
0.05 (7.84%)AT CLOSE (11:59 AM EDT)
0.58
0.01 (2.37%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
0.58
0.01 (2.37%)
🔴Market: CLOSED
Open?$0.63
High?$0.64
Low?$0.59
Prev. Close?$0.64
Volume?76.6K
Avg. Volume?31.3K
VWAP?$0.62
Rel. Volume?2.45x
Bid / Ask
Bid?$0.57 × 200
Ask?$0.58 × 300
Spread?$0.01
Midpoint?$0.58
Valuation & Ratios
Market Cap?4.1M
Shares Out?6.4M
Float?5.1M
Float %?79.5%
P/E Ratio?N/A
P/B Ratio?0.85
EPS?-$1.71
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
Employees
2
Market Cap
4.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2014-07-21
Address
1545 ROUTE 206 SOUTH
BEDMINSTER, NJ 07921
Phone: 908-484-8805
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.75Strong
Quick Ratio?2.75Strong
Cash Ratio?2.73Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A
P/B?
0.85CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
-0.0CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
-227.0%WEAK
ROA?
-152.1%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$108.0K
Fundamentals ratios updated end of day